> European big-pharma has discouraged generics and off-label, and has been assisted in this endeavor by the French state. Regarding France, I find odd (hypocri

> European big-pharma has discouraged generics and off-label, and has been assisted in this endeavor by the French state. Regarding France, I find odd (hypocrite?) that the French state is pushing against generics abroad, whereas locally the (state-run) social security system and health ministry are pushing for generics, because they are cheaper (and thus cheaper to refund).